| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
AliskirenArterial hypertension (BASKET)RAAS (Angiotensin receptor blockers) | 1 | 2008 | Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy. | 
| + | - | nl | Vasc Health Risk Manag 4(6):1205-20 (2008) Sureshkumar KK |
| 2 | 2007 | Aliskiren--an orally active renin inhibitor. Review of pharmacology, pharmacodynamics, kinetics, and clinical potential in the treatment of hypertension. |
| + | - | nl | Vasc Health Risk Manag 3(6):809-15 (2007) Allikmets K |
| 3 | 2007 | Direct renin inhibition: focus on aliskiren. |
| + | - | nl | J Manag Care Pharm 13(8 Suppl B):21-33 (2007) Pool JL |
| 4 | 2005 | Renin inhibition: what are the therapeutic opportunities? |
| + | - | nl | J Am Soc Nephrol 16(3):592-9 (2005) Fisher ND |
| 5 | 2008 | Oral direct renin inhibition: premise, promise, and potential limitations of a new antihypertensive drug. |
| + | - | nl | Am J Med 121(4):265-71 (2008) |
| 6 | 2008 | Interpretation of plasma renin concentration in patients receiving aliskiren therapy. |
| + | - | nl | Hypertension 51(1):15-8 (2008) |
| 7 | 2010 | New approaches to blockade of the renin-angiotensin-aldosterone system: characteristics and usefulness of the direct renin inhibitor aliskiren. |
| + | - | nl | J Pharmacol Sci 113(4):296-300 (2010) |
| 8 | 2008 | Pharmacokinetics and pharmacodynamics of aliskiren, an oral direct renin inhibitor. | 
| + | - | nl | Pharmacol Rep 60(5):623-31 (2008) |
| 9 | 2010 | Aliskiren and valsartan combination therapy for the management of hypertension. |
| + | - | nl | Vasc Health Risk Manag 6(-):711-22 (2010) |
| 10 | 2011 | A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors. |
| + | - | nl | Vasc Health Risk Manag 7(-):297-313 (2011) |
| 11 | 2010 | New class of agents for treatment of hypertension: focus on direct renin inhibition. |
| + | - | nl | Vasc Health Risk Manag 6(-):869-82 (2010) |
| 12 | 2009 | Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors. |
| + | - | nl | Vasc Health Risk Manag 5(1):453-63 (2009) |
